0.7001
Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
44.61%
3.4845
|
2.4096 | 4.3035 | 5.4308 | 8.5052 |
| Operating Income/Loss |
64.95%
-5.8505
|
-3.5469 | -6.6679 | -8.0011 | -10.17 |
| Nonoperating Income/Loss |
324.43%
0.4002
|
0.0943 | 0.2064 | 0.3128 | 0.4014 |
| Net Income/Loss |
57.86%
-5.4503
|
-3.4526 | -6.4615 | -7.6883 | -9.7673 |
| Basic Average Shares |
0.00%
60.32
|
60.32 | 0.0358 | 60.13 | 60.05 |
| Diluted Average Shares |
0.00%
60.32
|
60.32 | 0.0358 | 60.13 | 60.05 |
| Basic Earnings Per Share |
50.00%
-0.09
|
-0.06 | -0.10 | -0.13 | -0.16 |
| Diluted Earnings Per Share |
50.00%
-0.09
|
-0.06 | -0.10 | -0.13 | -0.16 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):